|
|
||||||||


* Graduate Program in Immunology and Molecular Pathogenesis, and Departments of
Neurology and
Pathology, Emory University School of Medicine, Atlanta, GA 30322
Previous studies using mast cell-deficient mice (W/Wv) revealed that mast cells influence disease onset and severity of experimental allergic/autoimmune encephalomyelitis (EAE), the murine model for multiple sclerosis. The mast cell populations of these mice can be restored by transferring bone marrow-derived mast cells (BMMCs). Studies using the W/Wv reconstitution model have lead to major advances in our understanding of mast cell roles in vivo. However, despite its common use, details regarding the sites and kinetics of mast cell repopulation have remained largely uncharacterized. In this study, we examined the kinetics and tissue distribution of green fluorescent protein+ BMMCs in reconstituted W/Wv mice to identify sites of mast cell influence in EAE. Reconstitution of naive animals with BMMCs does not restore mast cell populations to all organs, notably the brain, spinal cord, lymph nodes, and heart. Despite the absence of mast cells in the CNS, reconstituted mice exhibit an EAE disease course equivalent to that induced in wild-type mice. Mast cells are found adjacent to T cell-rich areas of the spleen and can migrate to the draining lymph node after disease induction. These data reveal that mast cells can act outside the CNS to influence EAE, perhaps by affecting the function of autoreactive lymphocytes.
This article has been cited by other articles:
![]() |
T. Kawakami A Crucial Door to the Mast Cell Mystery Knocked In J. Immunol., December 1, 2009; 183(11): 6861 - 6862. [Full Text] [PDF] |
||||
![]() |
S. Piconese, G. Gri, C. Tripodo, S. Musio, A. Gorzanelli, B. Frossi, R. Pedotti, C. E. Pucillo, and M. P. Colombo Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation Blood, September 24, 2009; 114(13): 2639 - 2648. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Nowak, C. T. Weaver, H. Turner, S. Begum-Haque, B. Becher, B. Schreiner, A. J. Coyle, L. H. Kasper, and R. J. Noelle IL-9 as a mediator of Th17-driven inflammatory disease J. Exp. Med., August 3, 2009; 206(8): 1653 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Sundstrom, G. A. Hair, A. A. Ansari, W. E. Secor, A. M. Gilfillan, D. D. Metcalfe, and A. S. Kirshenbaum IgE-Fc{epsilon}RI Interactions Determine HIV Coreceptor Usage and Susceptibility to Infection during Ontogeny of Mast Cells J. Immunol., May 15, 2009; 182(10): 6401 - 6409. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamura, N. Kambe, M. Saito, R. Nishikomori, Y.-G. Kim, M. Murakami, G. Nunez, and H. Matsue Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria J. Exp. Med., May 11, 2009; 206(5): 1037 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bennett, M.-R. Blanchet, L. Zhao, L. Zbytnuik, F. Antignano, M. Gold, P. Kubes, and K. M. McNagny Bone Marrow-Derived Mast Cells Accumulate in the Central Nervous System During Inflammation but Are Dispensable for Experimental Autoimmune Encephalomyelitis Pathogenesis J. Immunol., May 1, 2009; 182(9): 5507 - 5514. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Holdsworth and S. A. Summers Role of Mast Cells in Progressive Renal Diseases J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2254 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Byrne, A. Y. Limon-Flores, and S. E. Ullrich Mast Cell Migration from the Skin to the Draining Lymph Nodes upon Ultraviolet Irradiation Represents a Key Step in the Induction of Immune Suppression J. Immunol., April 1, 2008; 180(7): 4648 - 4655. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Ponomarev, K. Maresz, Y. Tan, and B. N. Dittel CNS-Derived Interleukin-4 Is Essential for the Regulation of Autoimmune Inflammation and Induces a State of Alternative Activation in Microglial Cells J. Neurosci., October 3, 2007; 27(40): 10714 - 10721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Christy and M. A. Brown The Multitasking Mast Cell: Positive and Negative Roles in the Progression of Autoimmunity J. Immunol., September 1, 2007; 179(5): 2673 - 2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Nigrovic, B. A. Binstadt, P. A. Monach, A. Johnsen, M. Gurish, Y. Iwakura, C. Benoist, D. Mathis, and D. M. Lee Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1 PNAS, February 13, 2007; 104(7): 2325 - 2330. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kitawaki, N. Kadowaki, N. Sugimoto, N. Kambe, T. Hori, Y. Miyachi, T. Nakahata, and T. Uchiyama IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells Int. Immunol., December 1, 2006; 18(12): 1789 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zareie, P. Fabbrini, L. H.P. Hekking, E. D. Keuning, P. M. ter Wee, R. H.J. Beelen, and J. van den Born Novel Role for Mast Cells in Omental Tissue Remodeling and Cell Recruitment in Experimental Peritoneal Dialysis J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3447 - 3457. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kanamaru, L. Scandiuzzi, M. Essig, C. Brochetta, C. Guerin-Marchand, Y. Tomino, R. C. Monteiro, M. Peuchmaur, and U. Blank Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis J. Immunol., May 1, 2006; 176(9): 5607 - 5615. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Thumbikat, C. Waltenbaugh, A. J. Schaeffer, and D. J. Klumpp Antigen-specific responses accelerate bacterial clearance in the bladder. J. Immunol., March 1, 2006; 176(5): 3080 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Timoshanko, R. Kitching, T. J. Semple, P. G. Tipping, and S. R. Holdsworth A Pathogenetic Role for Mast Cells in Experimental Crescentic Glomerulonephritis J. Am. Soc. Nephrol., January 1, 2006; 17(1): 150 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tsunoda, J. E. Libbey, L.-Q. Kuang, E. J. Terry, and R. S. Fujinami Massive Apoptosis in Lymphoid Organs in Animal Models for Primary and Secondary Progressive Multiple Sclerosis Am. J. Pathol., December 1, 2005; 167(6): 1631 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nguyen, A. J. Pace, and B. H. Koller Age-Induced Reprogramming of Mast Cell Degranulation J. Immunol., November 1, 2005; 175(9): 5701 - 5707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Weller, S. J. Collington, J. K. Brown, H. R.P. Miller, A. Al-Kashi, P. Clark, P. J. Jose, A. Hartnell, and T. J. Williams Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors J. Exp. Med., June 20, 2005; 201(12): 1961 - 1971. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |